Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 17 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
MindWave Innovations Inc. (NYSE American: APUS) Is ‘One to Watch’
The company is developing an institutional Digital Asset Treasury model focused on enabling corporations to…
-
American Fusion Inc. (AMFN) Aligns Corporate Identity with Fusion Energy Strategy
American Fusion Inc. has officially changed its corporate name and ticker symbol from Renewal Fuels…
-
Automation Without the Capital Expense: The Economics of RaaS Deployment
TechForce Robotics are advancing automation through a subscription-based RaaSP (Robotics-as-a-Service Provider) The company delivers a…